News

First House office will hold union vote today

On the question of taking action to lower prescription drug prices, progressive lawmakers are of two minds. Some argue that Congress should simply pass legislation to allow the government to set the price for prescription medications. That approach, whether wise on policy grounds or not, at least has the virtue of fidelity to our constitutional

Read More »

IP Leaders Join Forces to Counter Anti-IP Narratives

On the question of taking action to lower prescription drug prices, progressive lawmakers are of two minds. Some argue that Congress should simply pass legislation to allow the government to set the price for prescription medications. That approach, whether wise on policy grounds or not, at least has the virtue of fidelity to our constitutional

Read More »

IP Luminaries Launch Group To Promote, Defend Innovation

On the question of taking action to lower prescription drug prices, progressive lawmakers are of two minds. Some argue that Congress should simply pass legislation to allow the government to set the price for prescription medications. That approach, whether wise on policy grounds or not, at least has the virtue of fidelity to our constitutional

Read More »

Ex-patent officials, U.S. judges join lobbyist for IP policy push

On the question of taking action to lower prescription drug prices, progressive lawmakers are of two minds. Some argue that Congress should simply pass legislation to allow the government to set the price for prescription medications. That approach, whether wise on policy grounds or not, at least has the virtue of fidelity to our constitutional

Read More »

First House office will hold union vote today

On the question of taking action to lower prescription drug prices, progressive lawmakers are of two minds. Some argue that Congress should ...

IP Leaders Join Forces to Counter Anti-IP Narratives

On the question of taking action to lower prescription drug prices, progressive lawmakers are of two minds. Some argue that Congress should ...

IP Luminaries Launch Group To Promote, Defend Innovation

On the question of taking action to lower prescription drug prices, progressive lawmakers are of two minds. Some argue that Congress should ...

Ex-patent officials, U.S. judges join lobbyist for IP policy push

On the question of taking action to lower prescription drug prices, progressive lawmakers are of two minds. Some argue that Congress should ...
Scroll to Top